Assesses lysosomal acid lipase deficiency severity (Wolman disease in infants; CESD in older patients) using liver function tests, lipid profile, liver ultrasound/biopsy findings, and sebilapase alfa dosing.
Assesses lysosomal acid lipase deficiency severity (Wolman disease in infants; CESD in older patients) using liver function tests, lipid profile, liver ultrasound/biopsy findings, and sebilapase alfa dosing
Each component has a specific meaning:
Note: Interpret the lal deficiency result against the thresholds and context described above.
Enter the liver function tests, lipid profile, liver ultrasound/biopsy findings, sebilapase alfa dosing for the scenario you are assessing. Assesses lysosomal acid lipase deficiency severity (Wolman disease in infants; CESD in older patients) using liver function tests, lipid profile, liver ultrasound/biopsy findings, and sebilapase alfa dosing. Use the lal deficiency result to inform your calculation.